TrialPanorama/TrialPanorama-database huggingface dataset:
Primary endpoint: Change in Peer Assessment Rating score (PAR)
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Change in visual ability
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Vaccine confidence from the parents' perspective
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Vaccine confidence from the clinicians' perspective
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Vaccine confidence from the EBI Experts' perspective
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Ethanol-induced vestibular function decline
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Change in AUC[0-infinity] of Probe Drugs
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in AUC[0-last] of Probe Drugs
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Maximum Observed Plasma Concentration (Cmax) of Probe Drugs
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Contrast to noise ratio
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Verification of endotracheal tube position
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Bone marrow minimal residual disease (MRD)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Hematological outcomes
Primary endpoint: Objective Response Rate (ORR) After First BV Administration
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Progression Free Survival (PFS) After First BV Administration
Endpoint domain: Mortality/survival
Primary endpoint: Time to Next Treatment (TTNT) After First BV Administration
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Composite of serious perfusion-related complications
Endpoint domain: Adverse events/effects
Primary endpoint: Body composition, fat %
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Body composition, lean mass (kg)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Proportion of patients with persistent COVID-19 symptoms
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Severity of disease
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: efficacy of cholecalciferol therapy
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: safety of cholecalciferol therapy
Endpoint domain: Adverse events/effects
Primary endpoint: KODA score (entire small bowel)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Concentration of plasma S100A8/A9
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of risk behaviors observed
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Visual analogue scale (VAS) related to tinnitus
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Predictive value of internal jugular vein (IJV) cross sectional area
Endpoint domain: Physiological/clinical
Endpoint subdomain: Vascular outcomes
Primary endpoint: Intensive Care Unit Free days to Day 60
Endpoint domain: Mortality/survival
Primary endpoint: Test of Sensory Functions in Infants (TSFI)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Muscle tone evaluation
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Single nucleotide polymorphisms (SNPs) associated with traumatic brain injury
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Kiddy-KINDL-R
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Preschool Spence Anxiety Scale (PAS)
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: 5-Dimensional, 5-Level EuroQol Questionnaire (EQ-5D-5L)
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Scale of Psychological Well-Being (Ryff, 1989)
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: 24h area-under the plasma concentration time curve (AUC) of ELX/TEZ/IVA
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of patients with any device-related serious adverse event
Endpoint domain: Adverse events/effects
Primary endpoint: Patient's ability to complete the treatments
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Liver fat measurement
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Total adiposity measurement
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Montelukast plasma level
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change of the perfusion index
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Personalized model effectiveness
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Pathological diagnosis rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Changes in eyelash growth as per expert grading
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Changes in participant-perceived eyelash growth
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Microvessel imaging
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Composite of cardiovascular death, recurrent MI and repeated revascularization
Endpoint domain: Mortality/survival
Primary endpoint: Composite of minor and major bleeding events
Endpoint domain: Adverse events/effects
Primary endpoint: OUD treatment entry
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Total radioactivity recovered in urine
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Total radioactivity recovered in feces
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Urinary recovery (fet1-t2)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Absolute bioavailability (Fabs)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Changes in levels of rational and irrational beliefs
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Percentage of cells undergoing ferroptosis
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in carotid artery intima-media thickness (CIMT)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Post-induction MAP
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: step count
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Plaque stability of coronary atherosclerotic plaques
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Change of iron content in tissues between different time points
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Plasma concentration of Drospirenone
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: conversion rate to resection
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Houseman Brahman (HB) Level
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Patients' knowledge regarding cutaneous side-effects
Endpoint domain: Adverse events/effects
Primary endpoint: Patients' knowledge regarding nail and hair toxicities
Endpoint domain: Adverse events/effects
Primary endpoint: Patients' knowledge regarding dermo-cosmetics and aesthetic solutions
Endpoint domain: Adverse events/effects
Primary endpoint: maximum tolerated dose (MTD) or optimal biologic dose (OBD)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Oral Health-Related Quality of Life
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Total body weight loss percentage (TBWL%)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in glycated haemoglobin (HbA1c; mmol/mol)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Change in the number and dose of anti-diabetic medications
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Inter-rater reliability of spinal crepitus analysis
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Time of analysis of spinal crepitus
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: RMQ for pain and disability
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Verbal fluency score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Oxygenated hemoglobin change from baseline
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Intensity of post operative nausea and vomiting (PONV)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in visual field
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Absence of clinical relapse
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Eggerthella abundance
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Experience and perceptions after hospitalization
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Percent change from baseline in serum alkaline phosphatase (ALP)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Medium-load working memory performance
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Evaluation of the quality of life of patients with constipation (PAC-QOL)
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Maximum Plasma Concentration (Cmax) of MK-6552
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Peripheral serum GABA concentrations
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Short intracortical inhibition
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Change in peak volume of oxygen uptake (VO2peak)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Central sensitivity index
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mental pain
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Percentage correct in reading aloud the sentences
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Time required in read aloud of trained scripts
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Percentage correct in spontaneous production of the sentences
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Time required for spontaneous production of trained scripts
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Distinct acts of condomless anal sex (CAS)
Endpoint domain: Adverse events/effects
Primary endpoint: Lab-measured Performance of Gait Modification
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Real-world Performance of Gait Modification
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Satisfaction With the Treatment Program
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Women's pain levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Early postpartum health characteristics
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Fecal allantoin
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Area Under the Plasma Concentration Versus Time Curve From Time 0 Extrapolated to Infinity (AUC0-inf) of Gefurulimab
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Questionnaires completed
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Post operative Pulmonary Complication (PPC)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Change in average daily knee pain intensity
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Cumulative opioid consumption at post op day 14
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Number of ≥Grade 2 study related adverse events
Endpoint domain: Adverse events/effects
Primary endpoint: Recruitment (Patients per site per month)
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Change in plasma glucose during exercise
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: OA evaluation
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Clinical progression free survival (cPFS)
Endpoint domain: Mortality/survival
Primary endpoint: Explicit weight bias, mean score
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Malignant/Benign status by pathological examination
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Malignant/Benign status evaluated by serological risk model
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: sensitivity of bronchoscopic narrow-band imaging
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: specificity of bronchoscopic narrow-band imaging
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: positive predictive value of bronchoscopic narrow-band imaging
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: negative predictive value of bronchoscopic narrow-band imaging
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Thromboelastography
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: tPA-challenged Thromboelastography
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Delis-Kaplan Executive Function System Verbal Fluency Test score
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Oxygenated and deoxygenated hemoglobin change from baseline
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: LAC/PYR ratio
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Total Sodium Concentration
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: rate of response to treating postoperative depression
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in SEP2
Endpoint domain: Life impact
Endpoint subdomain: Sexual functioning
Primary endpoint: Change in SEP3
Endpoint domain: Life impact
Endpoint subdomain: Sexual functioning
Primary endpoint: Mean slope of the Cogstate composite Z score
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cognitive functioning
Primary endpoint: Proportion of patients with modified Rankin Score (mRS) 0 to 2
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Exercise capacity during a time trial
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in worst uremic pruritis severity rating
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Absenteeism from university
Endpoint domain: Life impact
Endpoint subdomain: Role functioning
Primary endpoint: Proportion of subjects with Plasma HIV-1 RNA below 400 copies/mL
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Unpleasantness of the pain
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Pain-related functional scale
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Percentage of Enrolled Subjects Who Agree With Randomization
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: DMD-IVR Effectiveness standard functional assessments: North Star Ambulatory Assessment (NSAA)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: DMD-IVR effectiveness measures with a Timed test 4 stair climb
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: DMD-IVR effectiveness measured joint range of movement using Goniometer
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of Follicles >18 mm on the day of HCG
Endpoint domain: Physiological/clinical
Endpoint subdomain: Reproductive system and breast outcomes
Primary endpoint: Number of Oocytes aspirated
Endpoint domain: Physiological/clinical
Endpoint subdomain: Reproductive system and breast outcomes
Primary endpoint: Fertilisation Rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: Reproductive system and breast outcomes
Primary endpoint: maximum oxygen consumption (VO2max) and anaerobic threshold (AT)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: maximum force measured in countermovement jump test
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: record time in 40-meter sprint test
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Variations of the response of the cortical network using High Resolution Electroencephalography before auditory stimuli
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Variations of the response of the cortical network using High Resolution Electroencephalography during auditory stimuli
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Variations of the response of the cortical network using High Resolution Electroencephalography after auditory stimuli
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Variations of the response of the cortical network using High Density Near Infrared Spectroscopy before auditory stimuli
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Bruce Protocol (Treadmill)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Improvement on discharge
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Transfer to another hospital for continued treatment
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Mortality during admission
Endpoint domain: Mortality/survival
Primary endpoint: Discharged against medical advice
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Migraine attack severity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Maximal voluntary isometric contraction (MVIC) of the toe flexors muscles
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Somatosensory recovery
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Enrolment Rate
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Follow-Up Rate
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Data Capture Rate
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Total body Vitiligo Area Scoring Index 50 (T-VASI50) at Week 52
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: DEXA
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Bioimpedance
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Sustained objective response rate in recurrent/progressive previously irradiated ACP
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Sustained objective response rate in measurable ACP post-surgery without prior radiation
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in advance care planning (ACP) engagement
Endpoint domain: Life impact
Endpoint subdomain: Delivery of care
Primary endpoint: Disability and Physical function
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Number of Patients with grade 1-5 adverse events
Endpoint domain: Adverse events/effects
Primary endpoint: potential efficacy
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Maximum curcumin tolerated dose
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Serious Adverse Events related to the device
Endpoint domain: Adverse events/effects
Primary endpoint: Successful Implantation Rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Adequacy of the sampled endometrial specimen for histopathology diagnosis
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Intensity of Engagement
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Clinical clearance rate of skin lesions
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes